Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ferric citrate versus calcium carbonate for control of CKD-MBD in peritoneal dialysis patients
TCTR20260803002Phase 4Enrolling by invitation
- Sponsor
- Bhumibol Adulyadej Hospital Research Center
- Start
- Sep 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of ferric citrate, calcium carbonate in hyperphosphatemia, chronic kidney disease-mineral and bone disorder (CKD-MBD), sponsored by Bhumibol Adulyadej Hospital Research Center. Started Sep 2026; status: enrolling by invitation.
02
Drugs
ferric citratecalcium carbonate
03
Conditions
hyperphosphatemiachronic kidney disease-mineral and bone disorder (CKD-MBD)
Beyond the preview
Go deeper on TCTR20260803002.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20260803002.